The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Troponin I Degradation and Covalent Complex Formation Accompanies Myocardial Ischemia/Reperfusion Injury
Open accessAbstract
Abstract —Selective troponin I (TnI) modification has been demonstrated to be in part responsible for the contractile dysfunction observed with myocardial ischemia/reperfusion injury. We have isolated and characterized modified TnI products in isolated rat hearts after 0, 15, or 60 minutes of ischemia followed by 45 minutes of reperfusion using affinity chromatography with cardiac troponin C (TnC) and an anti-TnI antibody, immunological mapping, reversed-phase high-performance liquid chromatography, and mass spectrometry. Rat cardiac TnI becomes progressively degraded from 210 amino acid residues to residues 1–193, 63–193, and 73–193 with increased severity of injury. Degradation is accompanied by formation of covalent complexes between TnI 1–193 and, respectively, TnC residues 1–94 and troponin T (TnT) residues 191–298. The covalent complexes are likely a result of isopeptide bond formation between lysine 193 of TnI and glutamine 191 of TnT by the cross-linking enzyme transglutaminase. With severe ischemia, cellular necrosis results in specific release of TnI 1–193 into the reperfusion effluent and TnT degradation in the myocardium (25-, 27-, and 33-kDa products). Two-dimensional electrophoresis demonstrated that phosphorylation of TnI prevents ischemia-induced degradation. This study characterized the modified TnI products in isolated rat hearts reperfused after a brief or severe period of ischemia, revealing the progressive nature of TnI degradation, changes in phosphorylation, and covalent complexes with ischemia/reperfusion injury. Finally, we propose a model for ischemia/reperfusion injury in which the extent of proteolytic and transglutaminase activities ultimately determines whether apoptosis or necrosis is achieved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Schägger, H., & von Jagow, G. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90587-2 · Cited by 11,444
Current Protocols in Protein Science
(2018) · Current Protocols in Protein Science · doi:10.1002/(issn)1934-3663 · Cited by 1,189
Apoptosis in Ischemic and Reperfused Rat Myocardium
Fliss, H., & Gattinger, D. (1996) · Circulation Research · doi:10.1161/01.res.79.5.949 · Cited by 797
Calpain: new perspectives in molecular diversity and physiological‐pathological involvement
Saido, T. C., Sorimachi, H., & Suzuki, K. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.11.8070630 · Cited by 660
G h : a GTP-Binding Protein with Transglutaminase Activity and Receptor Signaling Function
Nakaoka, H., Perez, D. M., Baek, K. J., Das, T., Husain, A., Misono, K., Im, M.-J., & Graham, R. M. (1994) · Science · doi:10.1126/science.7911253 · Cited by 547
Thin Filament-Mediated Regulation of Cardiac Contraction
Tobacman, L. S. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.002311 · Cited by 529
Wu, A. H. B., Feng, Y.-J., Moore, R., Apple, F. S., McPherson, P. H., Buechler, K. F., Bodor, G., for, F. T. A. A., & Standardization, C. C. S. O. C. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.6.1198 · Cited by 393
Role of Troponin I Proteolysis in the Pathogenesis of Stunned Myocardium
Gao, W. D., Atar, D., Liu, Y., Perez, N. G., Murphy, A. M., & Marban, E. (1997) · Circulation Research · doi:10.1161/01.res.0000435855.49359.47 · Cited by 392
MASS SPECTROMETRY OF PEPTIDES AND PROTEINS
Biemann, K. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.004553 · Cited by 390
Cited by
Molecular and Cellular Mechanisms of Myocardial Stunning
Bolli, R., & Marbán, E. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.609 · Cited by 1,041
It’s Time for a Change to a Troponin Standard
Jaffe, A. S., Ravkilde, J., Roberts, R., Naslund, U., Apple, F. S., Galvani, M., & Katus, H. (2000) · Circulation · doi:10.1161/01.cir.102.11.1216 · Cited by 643
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1
Kloner, R. A., & Jennings, R. B. (2001) · Circulation · doi:10.1161/hc4801.100038 · Cited by 634
Cardiac troponins: from myocardial infarction to chronic disease
Park, K. C., Gaze, D. C., Collinson, P. O., & Marber, M. S. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx183 · Cited by 510
Wang, W., Schulze, C. J., Suarez-Pinzon, W. L., Dyck, J. R. B., Sawicki, G., & Schulz, R. (2002) · Circulation · doi:10.1161/01.cir.0000028818.33488.7b · Cited by 484
Raedschelders, K., Ansley, D. M., & Chen, D. D. Y. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.11.004 · Cited by 388
Titin Isoform Switch in Ischemic Human Heart Disease
Neagoe, C., Kulke, M., del Monte, F., Gwathmey, J. K., de Tombe, P. P., Hajjar, R. J., & Linke, W. A. (2002) · Circulation · doi:10.1161/01.cir.0000029803.93022.93 · Cited by 382
Pathobiology of Troponin Elevations
White, H. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.029 · Cited by 381
Neri, M., Riezzo, I., Pascale, N., Pomara, C., & Turillazzi, E. (2017) · Mediators of Inflammation · doi:10.1155/2017/7018393 · Cited by 379
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I
Kedar, V., McDonough, H., Arya, R., Li, H.-H., Rockman, H. A., & Patterson, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404341102 · Cited by 347
Labugger, R., Organ, L., Collier, C., Atar, D., & Van Eyk, J. E. (2000) · Circulation · doi:10.1161/01.cir.102.11.1221 · Cited by 315
Schulz, R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105230 · Cited by 295
Preload Induces Troponin I Degradation Independently of Myocardial Ischemia
Feng, J., Schaus, B. J., Fallavollita, J. A., Lee, T.-C., & Canty, J. M. (2001) · Circulation · doi:10.1161/01.cir.103.16.2035 · Cited by 287
Biochemical markers of myocardial injury
Kemp, M., Donovan, J., Higham, H., & Hooper, J. (2004) · British Journal of Anaesthesia · doi:10.1093/bja/aeh148 · Cited by 286
Sawicki, G., Leon, H., Sawicka, J., Sariahmetoglu, M., Schulze, C. J., Scott, P. G., Szczesna-Cordary, D., & Schulz, R. (2005) · Circulation · doi:10.1161/circulationaha.104.531616 · Cited by 263
Transgenic Mouse Model of Stunned Myocardium
Murphy, A. M., Kögler, H., Georgakopoulos, D., McDonough, J. L., Kass, D. A., Van Eyk, J. E., & Marbán, E. (2000) · Science · doi:10.1126/science.287.5452.488 · Cited by 228
Self-citationOxidative Stress and Sarcomeric Proteins
Steinberg, S. F. (2013) · Circulation Research · doi:10.1161/circresaha.111.300496 · Cited by 195
Zhang, J., Guy, M. J., Norman, H. S., Chen, Y.-C., Xu, Q., Dong, X., Guner, H., Wang, S., Kohmoto, T., Young, K. H., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200258m · Cited by 194
Developing the next generation of cardiac markers: Disease-induced modifications of troponin I
McDonough, J. L., & Van Eyk, J. E. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2004.07.001 · Cited by 62
Self-citationThe continuing evolution of cardiac troponin I biomarker analysis: from protein to proteoform
Soetkamp, D., Raedschelders, K., Mastali, M., Sobhani, K., Bairey Merz, C. N., & Van Eyk, J. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1387054 · Cited by 36
“Modified forms of cTnI track differentially over time, with a distinct rise and fall profiles [47,50,62,68] suggesting a need for multiple proteoform profiling to comprehensively capture and assess individual risk.”
Metadata
- Authors
- McDonough, J. L., Arrell, D. K., & Van Eyk, J. E.
- Venue
- Circulation Research
- Published
- 1999-01-22
- Volume
- 84
- Issue
- 1
- Pages
- 9-20
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2165440393
- Cited by
- 317
- References
- 42
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.